Crystallex Closes Previously Announced Financing of 70,000,000 Units for C$35,000,000
30 Juin 2010 - 3:09PM
Marketwired
Crystallex International Corporation (TSX: KRY)(NYSE Amex: KRY)
announced today that it has completed its previously announced
financing of 70,000,000 units (the "Units") at C$0.50 per Unit (the
"Offering Price") for gross proceeds of C$35,000,000. Each Unit
consists of one common share (each, a "Common Share") and one-half
of one Common Share purchase warrant (each whole Common Share
purchase warrant, a "Warrant") of the Company. Each Warrant
entitles the holder to acquire one Common Share at a price of
C$0.70 until June 30, 2011. The Units were sold on a bought deal
basis by a syndicate of underwriters (the "Underwriters").
The Company has granted the Underwriters an over-allotment
option to purchase up to an additional 10,500,000 Units and/or up
to an additional 5,250,000 Warrants, exercisable at any time prior
to the date that is 30 days following the closing of the offering.
If this option is exercised in full, the gross proceeds to
Crystallex would increase to C$40,250,000.
Crystallex intends to use the net proceeds from the offering for
Las Cristinas project related expenses, debt service and for
general working capital purposes.
These securities have not been and will not be registered under
the United States Securities Act of 1933, as amended (the "U.S.
Securities Act"), or the securities laws of any state of the United
States and these securities may not be offered or sold, directly or
indirectly, within the United States or to, or for the account or
benefit of, a U.S. person (as defined in Regulation S under the
U.S. Securities Act) without registration under the U.S. Securities
Act and any applicable state securities laws unless an exemption
from registration is available. This news release is not an offer
to sell or the solicitation of an offer to buy the securities in
any jurisdiction.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press
release contains forward-looking statements within the meaning of
the United States Private Securities Litigation Reform Act of 1995
and applicable Canadian securities laws. Forward-looking statements
are based on estimates and assumptions made by Crystallex in light
of its experience and perception of historical trends, current
conditions and expected future developments, as well as other
factors that Crystallex believes are appropriate in the
circumstances. Many factors could cause Crystallex's actual
results, performance or achievements to differ materially from
those expressed or implied by the forward looking statements,
including: the conditions to the transactions contemplated by the
Agreement not being satisfied, gold price volatility; impact of any
hedging activities, including margin limits and margin calls;
discrepancies between actual and estimated production, between
actual and estimated reserves, and between actual and estimated
metallurgical recoveries; mining operational risk; regulatory
restrictions, including environmental regulatory restrictions and
liability; risks of sovereign investment; speculative nature of
gold exploration; dilution; competition; loss of key employees;
additional funding requirements; and defective title to mineral
claims or property. These factors and others that could affect
Crystallex's forward-looking statements are discussed in greater
detail in the section entitled "Risk Factors" in Crystallex's
Annual Information Form (which is included in the Annual Report on
Form 40-F that Crystallex files with the United States Securities
and Exchange Commission (the "SEC"), the Canadian Prospectus, dated
June 21, 2010, and elsewhere in documents filed from time to time
with the Canadian provincial securities regulators, the SEC and
other regulatory authorities. These factors should be considered
carefully, and persons reviewing this press release should not
place undue reliance on forward-looking statements. Crystallex has
no intention and undertakes no obligation to update or revise any
forward-looking statements in this press release, except as
required by law.
Contacts: Investor Relations Contact: Crystallex International
Corporation Richard Marshall, VP (800) 738-1577
info@crystallex.com
Crystallex (AMEX:KRY)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Crystallex (AMEX:KRY)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025